We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Discovery Group, DefiniGEN Collaborate

News   Jun 10, 2015

 
Horizon Discovery Group, DefiniGEN Collaborate
 
 
 

RELATED ARTICLES

Synthetic Molecule Invades Double-stranded DNA

News

Researchers have developed a synthetic molecule that can recognize and bind to double-stranded DNA or RNA under normal physiological conditions. The molecule could provide a new platform for developing methods for the diagnosis and treatment of genetic conditions.

READ MORE

$3.6 Million to Study Adverse Effects of Genome Editing

News

As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.

READ MORE

Nanoscaffold Developed to Enhance CNS Stem Cell Therapy

News

Biodegradable nanoscaffolds have been developed to overcome a host of challenges in stem cell therapies for CNS diseases and injuries

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE